VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 111 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $21,202,000 | -63.2% | 1,231,954 | -41.8% | 0.63% | -42.8% |
| Q2 2019 | $57,635,000 | +54.3% | 2,117,388 | +8.5% | 1.10% | +32.7% |
| Q1 2019 | $37,343,000 | +355.8% | 1,951,061 | +390.3% | 0.82% | +412.4% |
| Q3 2017 | $8,193,000 | +7.2% | 397,923 | -53.4% | 0.16% | -21.8% |
| Q2 2017 | $7,644,000 | -61.4% | 853,125 | -43.0% | 0.21% | -58.5% |
| Q1 2017 | $19,804,000 | +12.3% | 1,495,801 | +8.1% | 0.50% | -0.2% |
| Q4 2016 | $17,634,000 | +8.1% | 1,384,151 | +1.9% | 0.50% | +4.2% |
| Q3 2016 | $16,309,000 | +11.1% | 1,357,973 | +1.7% | 0.48% | +7.7% |
| Q2 2016 | $14,679,000 | +99.9% | 1,335,671 | +49.5% | 0.44% | +95.2% |
| Q1 2016 | $7,345,000 | -57.0% | 893,541 | -0.3% | 0.23% | -56.3% |
| Q4 2015 | $17,088,000 | – | 896,634 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 7,891,176 | $154,194,000 | 51.35% |
| Trustees of Princeton University | 203,638 | $3,979,000 | 4.13% |
| Casdin Capital, LLC | 1,135,000 | $22,178,000 | 3.10% |
| GREAT POINT PARTNERS LLC | 730,010 | $14,264,000 | 1.98% |
| BB BIOTECH AG | 2,532,641 | $49,488,000 | 1.43% |
| Aevitas Wealth Management, Inc. | 73,323 | $1,433,000 | 1.40% |
| Patriot Financial Group Insurance Agency, LLC | 64,256 | $1,256,000 | 1.34% |
| Virtus ETF Advisers LLC | 37,502 | $733,000 | 0.65% |
| Eventide Asset Management | 703,425 | $13,745,000 | 0.57% |
| THOMPSON DAVIS & CO., INC. | 11,951 | $234,000 | 0.56% |